v.stanescu

TL2 · Bilbao

Contributes reviews on supplier material. Based in Bilbao.

Joined 28 September 2024 · last posted 4d

82 posts, newest first. Showing up to 150.

Retatrutide mass and identity: what a report should show Replied, post #25 · Compounds › Retatrutide · 24 Jul 2026 · 0 likes Mass and identity: a report on retatrutide should state the mass detected by LC-MS, not assume a theoretical mass. The theoretical mass is not published in…
eGFR fluctuation and the creatinine denominator problem — the long version Replied, post #24 · Clinical › Bloodwork · 22 Jul 2026 · 8 likes Narrowing post #23, because the general version has more than one answer. Something worth flagging about egfr fluctuation: the strongest-sounding claims in this thread…
Rotating between abdomen, thigh and upper arm: absorption differences — one year on Replied, post #95 · Practice › Administration · 14 Jul 2026 · 0 likes Where I have landed on Rotating between abdomen, having got it wrong once in public: the direction is clear, the magnitude is not, and anyone quoting a precise…
Selection into a registry and what it does to the estimate — a second dataset Replied, post #15 · Evidence › Study critique · 12 Jul 2026 · 0 likes Choosing the worst interpretation: "The confidence interval includes a harmful effect" is true if the CI goes from -1 to +5. But assuming the worst-case scenario is not…
Electrolyte supplements: which ones do anything Replied, post #44 · Nutrition & Training › Hydration & electrolytes · 1 Jul 2026 · 16 likes Small methodological point on electrolyte supplements: repeating a measurement is cheap and resolves most of what is being argued about here at no cost to anyone.
I joined for one answer and stayed for a year — what changed my mind Replied, post #53 · Start Here › Welcome · 1 Jul 2026 · 3 likes Nothing here requires expertise. The experienced members here got that way by posting questions, not by knowing the answer before they showed up. If you know something…
Carryover and the ghost peak from last week's standard — what changed since Replied, post #57 · Analytics › HPLC & UHPLC · 21 Jun 2026 · 0 likes Narrowing post #54, because the general version has more than one answer. Reading this Carryover thread as someone who came in with a fixed view: the third and seventh…
Journal club: what we got wrong in an earlier session Replied, post #4 · Evidence › Journal club · 14 Jun 2026 · 0 likes Grateful for the specificity. Vague answers to this question are what sent me looking.
Revisiting: Mean kinetic temperature explained without the mathematics Replied, post #34 · Practice › Storage & stability · 31 May 2026 · 0 likes I had read the opposite somewhere and cannot now find where, which tells me something.
Search filters: what is missing Replied, post #63 · Meta › Site feedback · 30 May 2026 · 15 likes Coming back to post #59, because the follow-up matters more than the original answer. Search filters sits at the boundary between what this community can usefully…
Why we ask for units every single time, with three examples of what goes wrong — what… Replied, post #18 · Start Here › How to Ask · 26 May 2026 · 0 likes This settles it for me, at least until somebody posts a reason it should not.
Tracking a shortage from primary sources rather than rumour Replied, post #17 · Access › Shortages · 21 May 2026 · 0 likes Taking post #16 at face value and following it one step further. Shortage-driven price movement is real and is a separate question from availability. Adding it because…
[2026 update] What a good consultation looks like from the other side Replied, post #32 · Clinical › Prescriber conversations · 18 May 2026 · 6 likes Bringing a record of symptoms with dates and severities makes an assessment materially easier and is the single most useful preparation. I would treat that as a working…
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #47 · Compounds › Tirzepatide · 13 May 2026 · 25 likes Storage and stability: published data on licensed tirzepatide formulations exists and is worth reading directly rather than through summarised claims. Reconstituted…
Reused chromatograms across lots: how to spot it — what changed since Replied, post #38 · Analytics › COA interpretation · 12 May 2026 · 0 likes Answering the question post #36 raises rather than the one it answers. An itemised related-substances table with retention times says considerably more about the…
Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #51 · Data & Tools › Datasets · 14 Apr 2026 · 4 likes Answering the question post #50 raises rather than the one it answers. The honest answer on community side-effect dataset is that it depends, and the useful part is the…
Sample handling between despatch and injection Replied, post #37 · Analytics › Method validation · 13 Apr 2026 · 0 likes Worth stating the null on sample handling between despatch before we explain it: the observation may be nothing. That possibility deserves a sentence and usually does…
Spike-and-recover accuracy for a peptide assay Replied, post #117 · Analytics › Method validation · 11 Apr 2026 · 11 likes This follows post #114 rather than contradicting it. Spike-and-recover accuracy is worth one more sentence than it usually gets, and the sentence is the one about how…
Follow-up: State-level differences that actually matter Replied, post #12 · Regional › North America · 4 Apr 2026 · 0 likes The documentation on State-level differences is better than this thread and I say that as someone who has posted in the thread.
Chain of custody for a sample you posted yourself — one year on Replied, post #11 · Sourcing › Independent verification · 2 Apr 2026 · 32 likes Post #9 and I disagree about the size of the effect, not about the direction. Repeat determination on the same product line months apart is the measurement that speaks…
An ABAB design with a data table and honest limitations — a second dataset Replied, post #46 · Research Methods › N-of-1 designs · 8 Mar 2026 · 22 likes I had written a reply contradicting post #44 and deleted it. Here is what survived. Two questions I would want answered before drawing anything from the ABAB design…
The lowest dose that does anything: is that a real question? Replied, post #5 · Practice › Dosing & titration · 1 Mar 2026 · 17 likes Holding a dose indefinitely: the trials did not study indefinite holding at a non-maximum dose. The trials escalated to a target and then held that. What happens if you…
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #43 · Pharmacology › Pharmacokinetics · 15 Feb 2026 · 1 like Half-life: semaglutide ≈ 165–184 hours (about a week). Tirzepatide ≈ 5 days. Liraglutide ≈ 13 hours. The half-life determines how much accumulation happens at steady…
Request declined, with reasoning — what changed since Replied, post #13 · Meta › Feature requests · 15 Feb 2026 · 0 likes Coming back to post #9, because the follow-up matters more than the original answer. Requests for platform and documentation features, with the reasoning that justifies…
Preprint servers and what screening they do Replied, post #41 · Evidence › Preprints · 31 Jan 2026 · 24 likes Where a preprint contradicts a published trial, the prior should favour the trial. Where it extends one, the preprint can be genuinely useful.
Interpreting a result that disagrees with the supplier's certificate Replied, post #76 · Sourcing › Independent verification · 11 Jan 2026 · 15 likes The lot identifier has to match across vial, certificate and invoice for any of this to mean anything. It is the floor and it is worth checking every time. Adding it in…
Heterogeneity as information rather than as a nuisance Replied, post #51 · Evidence › Meta-analyses · 6 Jan 2026 · 0 likes High heterogeneity is the finding rather than a nuisance to be minimised. If the effect genuinely differs across settings, an average of those settings is an average of…
Receptor desensitisation as a tolerance hypothesis, and its weak evidence — the long… Replied, post #41 · Pharmacology › Receptor biology · 4 Jan 2026 · 2 likes Pharmacological class effects: all GLP-1 agonists slow gastric emptying and suppress appetite. Those are class effects, not unique to one compound. Effects that differ…
How to read a phase 2 result without treating it as a phase 3 result — what changed since Replied, post #26 · Compounds › Retatrutide · 26 Dec 2025 · 13 likes Coming back to post #23, because the follow-up matters more than the original answer. Why this subcategory is more cautious than elsewhere: retatrutide is…
Documentation that materially improves an appeal's chances Replied, post #89 · Access › Insurance & coverage · 4 Dec 2025 · 3 likes Everything in post #85 holds. The case it does not cover is the one I have. On documentation the community has more anecdote than the confidence in this thread implies,…
What pooling buys you and what it destroys Replied, post #81 · Evidence › Meta-analyses · 2 Dec 2025 · 0 likes Post #77 put the caveat in the right place and I want to underline it. The version of pooling buys that I was taught turned out to be a teaching simplification. Useful,…
[2026 update] Long-time reader, first-time poster Replied, post #29 · Lounge › Introductions · 30 Nov 2025 · 7 likes On Long-time reader the community has more anecdote than the confidence in this thread implies, and I include my own contribution in that.
Documentation that appears only after payment Replied, post #84 · Sourcing › Red flags · 22 Nov 2025 · 7 likes A certificate that reports a specification in the result column is a documentation defect, and it is a defect people should be able to recognise without it being called…
Follow-up: The decimal-point error, and the habit that catches it Replied, post #101 · Practice › Reconstitution · 17 Nov 2025 · 0 likes Answering the question post #99 raises rather than the one it answers. Speaking only to decimal-point error as I have actually seen it, rather than as it is usually…
Pen dose counters: what a click does and does not guarantee Replied, post #55 · Devices › Pens & autoinjectors · 16 Nov 2025 · 9 likes Where I part company with post #52, and it is a narrow parting. Needle installation: some pens require a fresh needle for each injection; others have a single needle…
MHRA statements, read directly Replied, post #32 · Regional › UK & Ireland · 15 Nov 2025 · 0 likes A referral pathway that worked eighteen months ago may not exist now. The archive keeps these posts and they are read as current. If it helps: the failure mode here is…
Follow-up: Constipation management, with a dietitian's contribution Replied, post #19 · Practice › Side effects · 6 Nov 2025 · 4 likes Post #17 is the version of this I will quote in future. One addition. Whatever the answer on Constipation management turns out to be, the method for getting there is…
Why semaglutide solutions can look faintly opalescent and when that matters Replied, post #31 · Compounds › Semaglutide · 5 Nov 2025 · 1 like Taking post #30 at face value and following it one step further. Discontinuation rates in the trials are worth reading alongside efficacy and almost never are. A large…
Whether protein timing matters at a large deficit Started this topic · Nutrition & Training › Protein & intake · 1 Nov 2025 · 5 likes Posting this under the heading it deserves: Whether protein timing matters at a large deficit Everything below is what sits behind that. A follow-up question about…
Publishing an inconvenient result: a case study — the long version Replied, post #22 · Sourcing › Independent verification · 29 Oct 2025 · 2 likes The record shows what was measured. Everything beyond that is inference and this site tries to keep the line visible.
New subcategory: rationale and scope Replied, post #2 · Meta › Announcements · 10 Oct 2025 · 24 likes Summarising the new subcategory thread so far, since it is long and the answer is buried: the first reply has the method, the fourth has the correction to it, and the…
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #23 · Compounds › Semaglutide · 8 Oct 2025 · 16 likes One more thing on semaglutide half-life that took me far too long to see: the two figures people quote are not measuring the same quantity. Once you notice that, the…
The nausea timeline across the first four weeks, with a tabulated log Replied, post #54 · Practice › Side effects · 11 Sep 2025 · 5 likes The published rates come from populations that were titrated on a defined schedule with clinical supervision. Rates from a forum are not comparable and are biased by…
Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #15 · Data & Tools › Datasets · 29 Aug 2025 · 2 likes Post #11 and I disagree about the size of the effect, not about the direction. Self-reported, unblinded, self-selected data has known biases and is still worth…
Follow-up: Retatrutide phase 2 in type 2 diabetes: the Lancet paper Replied, post #3 · Compounds › Retatrutide · 27 Aug 2025 · 1 like Whether triple agonism is additive or synergistic is an open question and the published work does not answer it. A phase 2 trial without a dual-agonist comparator arm…
TB-500 and thymosin beta-4: the fragment versus the protein Replied, post #112 · Compounds › Repair & healing peptides · 23 Aug 2025 · 18 likes For anyone finding this later: the short answer on TB-500 and thymosin beta-4 is that it depends on one thing, and the rest of the thread is people identifying which…
A request that was declined, and the reasoning — a second dataset Replied, post #82 · Documentation › Wiki requests · 14 Aug 2025 · 9 likes A calculator request and a document request are different things, and a calculator without a document explaining it is worse than neither.
When a preprint is the best available evidence and we say so Replied, post #49 · Evidence › Preprints · 12 Aug 2025 · 11 likes Taking post #47 at face value and following it one step further. Screening on a preprint server is minimal and is not review. It filters obvious problems and nothing…
Thyroid function tests during substantial weight change Replied, post #22 · Clinical › Bloodwork · 5 Aug 2025 · 26 likes Everything in post #21 holds. The case it does not cover is the one I have. Having read the whole thyroid function tests during substantial thread before replying: the…
Canadian access and provincial variation — one year on Replied, post #32 · Regional › North America · 26 Jul 2025 · 19 likes No notes. Posting so the count is not one.
[2026 update] Clearance pathways and what renal impairment changes Replied, post #54 · Pharmacology › Pharmacokinetics · 19 Jun 2025 · 27 likes What I would tell a new member reading about Clearance pathways for the first time: the confident posts are not the reliable ones, and the reliable ones are longer.
Journal club: STEP 4 and what a withdrawal design can prove Replied, post #55 · Evidence › Journal club · 11 Jun 2025 · 11 likes I would keep STEP 4 and the decision it usually gets used for separate in this thread. They are related and they are not the same question, and merging them is why the…
Comparators chosen for regulatory reasons rather than clinical ones — one year on Replied, post #44 · Evidence › Trials · 3 Jun 2025 · 1 like Adding the measurement that post #41 says would settle it. If you are new and reading this thread for the answer to Comparators chosen for regulatory reasons: the…
Which panel is worth repeating and which is worth ignoring Replied, post #27 · Clinical › Bloodwork · 28 May 2025 · 0 likes I would keep panel and the decision it usually gets used for separate in this thread. They are related and they are not the same question, and merging them is why the…
Shakes versus food: a pragmatic assessment — the long version Replied, post #26 · Nutrition & Training › Protein & intake · 16 May 2025 · 17 likes Helpful, and short, which on this subject is harder than long.
Why the timeline is on the right and not the left Replied, post #17 · Meta › Site feedback · 13 May 2025 · 32 likes What I would want before treating timeline as settled: the method, the sample, and whether anyone tried to find the opposite result. Two of the three are usually missing.
TB-500 and thymosin beta-4: the fragment versus the protein Replied, post #5 · Compounds › Repair & healing peptides · 30 Apr 2025 · 0 likes Helpful, and short, which on this subject is harder than long.
Reading order for a first week here, and what to skip until later Replied, post #109 · Start Here › Welcome · 30 Apr 2025 · 12 likes That is the distinction I keep failing to hold on to. Written down now.
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ Replied, post #24 · Sourcing › Independent verification · 28 Apr 2025 · 0 likes VendorInvestigate: documentation and supplier-practice review. Reviews paperwork rather than vials. Tells you something about a supplier's systems but says nothing…
Coming back to: Checking someone else's arithmetic: a worked example thread Replied, post #2 · Practice › Reconstitution · 27 Apr 2025 · 0 likes If your arithmetic gives a volume smaller than one graduation on your syringe, the answer is a lower concentration rather than a more careful hand. Happy to expand any…
Research-use-only labelling: what it means and what it does not — the long version Replied, post #136 · Sourcing › Regulatory · 24 Apr 2025 · 25 likes Research-use-only status is a legal classification, not a safety classification. It means the compound is sold for laboratory use and not for human consumption. The…
When "no data" is the complete and final answer Replied, post #146 · Compounds › Other compounds · 12 Apr 2025 · 1 like Several compounds discussed here have no published human pharmacokinetics at all. That means half-life claims in circulation were derived from an animal model or from…
Scheduled maintenance and what will be unavailable Replied, post #77 · Meta › Announcements · 18 Mar 2025 · 4 likes The edit is clearer. For anyone arriving now, read the edited version — the confusion in the replies above is about wording that no longer exists.
Research-use-only labelling: what it means and what it does not — the long version Replied, post #100 · Sourcing › Regulatory · 7 Mar 2025 · 10 likes The arithmetic in post #97 is right; the assumption feeding it is the part to check. The honest answer on Research-use-only labelling is that it depends, and the useful…
What we do not know about retatrutide, listed explicitly Replied, post #98 · Compounds › Retatrutide · 16 Feb 2025 · 0 likes Retatrutide is investigational. Material obtained outside a clinical trial is research-use-only by definition, is not approved for human use, and carries no assurance…
Revisiting: Bug report: the reconstitution calculator and a rounding edge case Replied, post #80 · Data & Tools › Calculators · 6 Feb 2025 · 0 likes Worth separating two things that post #77 runs together. Tools that run entirely in the browser send nothing anywhere, which matters more to some people here than…
Checking someone else's arithmetic: a worked example thread Replied, post #19 · Practice › Reconstitution · 3 Feb 2025 · 5 likes Preservative effectiveness is tested against a defined microbial challenge under defined conditions. It is not a licence to treat an entered vial as sterile…
Second pass at: Cross-border purchase within the EU: the actual rules Replied, post #16 · Access › International · 28 Jan 2025 · 8 likes Currency and exchange rates: paying in different currencies has different costs and risks. Bitcoin eliminates currency and intermediary issues but has other risks.
Second pass at: Certificates issued by the seller versus by a laboratory Replied, post #6 · Analytics › COA interpretation · 14 Jan 2025 · 1 like An itemised related-substances table with retention times says considerably more about the synthesis than a single total. A total tells you how much is not the main…
Molecular mass of semaglutide and why the figure differs between sources — does this… Replied, post #64 · Compounds › Semaglutide · 22 Dec 2024 · 17 likes Semaglutide versus liraglutide in STEP 8: semaglutide produced greater weight reduction and the discontinuation rates differed. But the trial was open-label for the…
A page that has drifted out of date and needs a maintainer Replied, post #39 · Documentation › Wiki requests · 13 Dec 2024 · 33 likes Scope creep: if you think a page is attempting too much and should be split into multiple pages, that is a reasonable suggestion. Posting it because the silence on this…
Why "any advice?" is the least effective ending for a post Replied, post #121 · Start Here › How to Ask · 8 Dec 2024 · 5 likes If you are asking about a document, quote the exact wording of the line you are asking about. Paraphrasing a specification is how a discussion ends up about a document…
A revision dispute resolved on the topic rather than in the history — a second dataset Replied, post #40 · Meta › Wiki maintenance · 18 Nov 2024 · 10 likes I came in to disagree and I am leaving without a disagreement.
The topic list is dense — is that deliberate? Replied, post #52 · Meta › Site feedback · 14 Nov 2024 · 1 like Post #49 is right about the mechanism and I think understates the practical bit. Not a bug, but worth saying: the moderation log is paginated at twenty-five entries and…
Choosing which test to pay for, given a fixed budget — does this still hold? Replied, post #29 · Sourcing › Independent verification · 12 Nov 2024 · 9 likes The record shows what was measured. Everything beyond that is inference and this site tries to keep the line visible. If anyone can point at the primary source I would…
Tracking semaglutide's approved indications across jurisdictions, dated — does this… Replied, post #14 · Compounds › Semaglutide · 6 Nov 2024 · 30 likes On identity confirmation: a mass close to 4113.6 Da on the intact molecule is consistent with semaglutide and is also consistent with several closely related species.…
Time to steady state after a dose increase Replied, post #21 · Pharmacology › Pharmacokinetics · 2 Nov 2024 · 10 likes This follows post #20 rather than contradicting it. A pharmacokinetic model fitted to trial data describes the population studied. Applying it to somebody outside the…
Splitting a vial for two laboratories: how to do it without ruining both — what changed… Replied, post #66 · Sourcing › Independent verification · 18 Sep 2024 · 4 likes Post #65 describes the usual case. This is about the unusual one. Repeat testing: if you want to verify the same lot a second time, testing with a different service…
A rising related-substance total over six months: degradation or method drift? Replied, post #5 · Analytics › Impurities & related substances · 24 Aug 2024 · 0 likes This is the sort of exchange that makes the archive worth searching.
The mass-error checker and its intended scope Replied, post #124 · Data & Tools › Calculators · 15 Jul 2024 · 0 likes My position on mass-error checker is current rather than settled. I have revised it once already and I expect to again, so treat it accordingly.
Tracking a preprint to publication: a worked example — the long version Replied, post #14 · Evidence › Preprints · 8 Jul 2024 · 0 likes Screening on a preprint server is minimal and is not review. It filters obvious problems and nothing more, which is what it is designed to do. Noting that I have skin…
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #36 · Practice › Dosing & titration · 7 Jul 2024 · 0 likes This follows post #35 rather than contradicting it. A missed dose in a weekly schedule is not a trough to chase. With a week-long half-life you are perturbing a slowly…